AU2002336472B2 - Inhibition of exoprotein production using aromatic compositions - Google Patents

Inhibition of exoprotein production using aromatic compositions Download PDF

Info

Publication number
AU2002336472B2
AU2002336472B2 AU2002336472A AU2002336472A AU2002336472B2 AU 2002336472 B2 AU2002336472 B2 AU 2002336472B2 AU 2002336472 A AU2002336472 A AU 2002336472A AU 2002336472 A AU2002336472 A AU 2002336472A AU 2002336472 B2 AU2002336472 B2 AU 2002336472B2
Authority
AU
Australia
Prior art keywords
active ingredient
exoprotein
production
group
absorbent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2002336472A
Other languages
English (en)
Other versions
AU2002336472A1 (en
Inventor
Richard A Proctor
Rae Ellen Syverson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kimberly Clark Worldwide Inc
Original Assignee
Kimberly Clark Worldwide Inc
Kimberly Clark Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/969,299 external-priority patent/US20030135173A1/en
Priority claimed from US09/969,391 external-priority patent/US7022333B2/en
Priority claimed from US09/969,218 external-priority patent/US7026354B2/en
Application filed by Kimberly Clark Worldwide Inc, Kimberly Clark Corp filed Critical Kimberly Clark Worldwide Inc
Publication of AU2002336472A1 publication Critical patent/AU2002336472A1/en
Application granted granted Critical
Publication of AU2002336472B2 publication Critical patent/AU2002336472B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/216—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
AU2002336472A 2001-10-02 2002-09-09 Inhibition of exoprotein production using aromatic compositions Ceased AU2002336472B2 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US09/969,299 US20030135173A1 (en) 2001-10-02 2001-10-02 Inhibition of exoprotein production in absorbent articles using aromatic compositions
US09/969,218 2001-10-02
US09/969,391 US7022333B2 (en) 2001-10-02 2001-10-02 Inhibition of exoprotein production in non-absorbent articles uisng aromatic compositions
US09/969,218 US7026354B2 (en) 2001-10-02 2001-10-02 Aromatic compositions for the inhibition of exoprotein production from gram positive bacteria
US09/969,299 2001-10-02
US09/969,391 2001-10-02
PCT/US2002/028756 WO2003030953A1 (en) 2001-10-02 2002-09-09 Inhibition of exoprotein production using aromatic compositions

Publications (2)

Publication Number Publication Date
AU2002336472A1 AU2002336472A1 (en) 2003-07-03
AU2002336472B2 true AU2002336472B2 (en) 2007-08-23

Family

ID=27420759

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002336472A Ceased AU2002336472B2 (en) 2001-10-02 2002-09-09 Inhibition of exoprotein production using aromatic compositions

Country Status (9)

Country Link
EP (1) EP1432459A1 (pt)
JP (1) JP2005523239A (pt)
KR (1) KR100918887B1 (pt)
AR (1) AR037505A1 (pt)
AU (1) AU2002336472B2 (pt)
BR (1) BR0212679A (pt)
CA (1) CA2461291A1 (pt)
MX (1) MXPA04002474A (pt)
WO (1) WO2003030953A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009007799B4 (de) * 2009-02-06 2010-10-14 ITM Isotopen Technologien München AG Molekül zur Funktionalisierung eines Trägers, Bindung eines Radionuklids an den Träger und Radionuklidgenerator zur Herstellung des Radionuklids sowie Herstellungsverfahren
EP3223764B1 (en) * 2014-11-27 2023-10-25 Yeditepe Universitesi Antimicrobial and antiviral hygienic products
WO2018064978A1 (zh) * 2016-10-09 2018-04-12 曾忠铭 一种抑菌剂配伍在制备阴道用组合物中的用途与阴道用组合物

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3317376A (en) * 1963-02-12 1967-05-02 Robert I Schattner Germicidal fabric
US4470978A (en) * 1978-07-25 1984-09-11 Abic Ltd. Synergistic antibacterial composition
US4560549A (en) * 1983-08-24 1985-12-24 Lever Brothers Company Method of relieving pain and inflammatory conditions employing substituted salicylamides
US4582717A (en) * 1982-02-06 1986-04-15 Bayer Aktiengesellschaft Process for production of vaginal tampons containing pharmaceutical active compound
GB2186486A (en) * 1986-02-13 1987-08-19 Smith & Nephew Ass Antibacterial dressing
US5180749A (en) * 1989-08-22 1993-01-19 Sterling Winthrop, Inc. Antimicrobial composition
US5668097A (en) * 1994-08-12 1997-09-16 The Procter & Gamble Company Uncomplexed cyclodextrin solutions for odor control on inanimate surfaces
US5895643A (en) * 1994-04-05 1999-04-20 Beiersdorf Ag Deodorizing and anti-microbial compositions for use in cosmetic or topical preparations

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5476455A (en) * 1993-01-11 1995-12-19 Silber; Arthur L. Toxicity resistant tampon structure
JPH07289575A (ja) * 1994-04-27 1995-11-07 Okamoto Ind Inc 香料添加コンドーム及びコンドームへの香料添加方法
DE4434781A1 (de) * 1994-09-29 1996-04-04 Beiersdorf Ag Verwendung von Fettsäureestern zur Bekämpfung von Superinfektionen
AU6253996A (en) * 1995-06-07 1996-12-30 Kimberly-Clark Worldwide, Inc. Inhibition of exoprotein in absorbent article
JPH09108257A (ja) * 1995-10-23 1997-04-28 Shiyouichi Masugi 蓄光性クリーム及びラテックス製コンドーム
GB9612595D0 (en) * 1996-06-15 1996-08-21 Smithkline Beecham Plc Composition
WO1998011888A1 (en) * 1996-09-19 1998-03-26 American Home Products Corporation Method of treating urinary incontinence
ES2255730T3 (es) * 1997-04-18 2006-07-01 Ganeden Biotech, Inc. Utilizacion topica de esporas de bacilos probioticos para prevenir o tratar las infecciones microbianas.
KR20010013377A (ko) * 1997-06-04 2001-02-26 데이비드 엠 모이어 마일드한 잔류성 항균 조성물
US6353004B1 (en) * 1997-07-14 2002-03-05 Adolor Coporation Peripherally acting anti-pruritic opiates
AU5930898A (en) * 1998-01-28 1999-08-16 Procter & Gamble Company, The Antimicrobial hydrogel forming absorbent polymers
EP1024808A1 (en) * 1998-04-11 2000-08-09 Errekappa Euroterapici S.p.a. Pharmaceutical preparations containing hydrosoluble ketoprofen salts and their application
FR2777783A1 (fr) * 1998-04-24 1999-10-29 Innothera Lab Sa Association pharmaceutique d'imidazoles pour le traitement local des vulvo-vaginites infectieuses et des vaginoses
KR100563881B1 (ko) * 1998-05-29 2006-03-28 킴벌리-클라크 월드와이드, 인크. 천연 및 합성 중합체에 의한 향상된 냄새 흡수

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3317376A (en) * 1963-02-12 1967-05-02 Robert I Schattner Germicidal fabric
US4470978A (en) * 1978-07-25 1984-09-11 Abic Ltd. Synergistic antibacterial composition
US4582717A (en) * 1982-02-06 1986-04-15 Bayer Aktiengesellschaft Process for production of vaginal tampons containing pharmaceutical active compound
US4560549A (en) * 1983-08-24 1985-12-24 Lever Brothers Company Method of relieving pain and inflammatory conditions employing substituted salicylamides
GB2186486A (en) * 1986-02-13 1987-08-19 Smith & Nephew Ass Antibacterial dressing
US5180749A (en) * 1989-08-22 1993-01-19 Sterling Winthrop, Inc. Antimicrobial composition
US5895643A (en) * 1994-04-05 1999-04-20 Beiersdorf Ag Deodorizing and anti-microbial compositions for use in cosmetic or topical preparations
US5668097A (en) * 1994-08-12 1997-09-16 The Procter & Gamble Company Uncomplexed cyclodextrin solutions for odor control on inanimate surfaces

Also Published As

Publication number Publication date
WO2003030953A1 (en) 2003-04-17
KR100918887B1 (ko) 2009-09-23
EP1432459A1 (en) 2004-06-30
CA2461291A1 (en) 2003-04-17
BR0212679A (pt) 2005-04-12
KR20040044950A (ko) 2004-05-31
JP2005523239A (ja) 2005-08-04
MXPA04002474A (es) 2004-05-31
AR037505A1 (es) 2004-11-17

Similar Documents

Publication Publication Date Title
US7056891B2 (en) Method to produce a tampon that inhibits exoprotein production from gram positive bacteria
US6531435B1 (en) Compositions for the inhibition of exoprotein production from Gram positive bacteria
US6821999B2 (en) Methods for inhibiting the production of TSST-1
US20060135616A1 (en) Aromatic compositions for the inhibition of exoprotein production from gram positive bacteria
US20100274071A1 (en) Aromatic Compositions As Inhibitors Of Exoprotein Production In Non-Absorbent Articles
US20080096850A1 (en) Methods for inhibiting the production of tsst-1
AU2002336472B2 (en) Inhibition of exoprotein production using aromatic compositions
US7118759B2 (en) Absorbent articles containing additives
US20080033382A1 (en) Inhibition of exoprotein production in absorbent articles using aromatic compositions
AU2002336472A1 (en) Inhibition of exoprotein production using aromatic compositions
AU2002228597B2 (en) Inhibition of exoprotein production from grampositive bacteria
US8084046B2 (en) Inhibition of exoprotein production in absorbent articles using isoprenoids
AU2002326861B2 (en) Inhibition of exoproteins using isoprenoids
US7348023B2 (en) Absorbent articles containing additives
US20060067990A1 (en) Absorbent articles for inhibiting the production of exoproteins
AU2002228597A1 (en) Inhibition of exoprotein production from grampositive bacteria
WO2003028777A1 (en) Inhibition of exoproteins using isoprenoids
AU2002326861A1 (en) Inhibition of exoproteins using isoprenoids
AU2005292655A1 (en) Non-absorbent and absorbent articles for inhibiting the production of exoproteins

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired